Stonebrook Private’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Stonebrook Private's VRTX Position: Q2 2026 in Review
Stonebrook Private opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 452 shares worth $225K. The stake represents 0.04% of the portfolio and ranks #233 among its holdings. This is a return to the name: Stonebrook Private previously reported a position in VRTX as recently as Q2 2025.
Stonebrook Private first reported a position in VRTX in Q2 2025 and has held it in 2 quarters since. The position peaked at $237K in Q2 2025. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Stonebrook Private held 452 shares of Vertex Pharmaceuticals worth $225K as of Q2 2026.
- Vertex Pharmaceuticals was a new Stonebrook Private position in Q2 2026.
- Vertex Pharmaceuticals made up 0.04% of Stonebrook Private's portfolio in Q2 2026, its #233 holding.
- Stonebrook Private first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
- Stonebrook Private's Vertex Pharmaceuticals position peaked at $237K in Q2 2025.
- 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Stonebrook Private's 13F filing for Q2 2026, filed 14 Aug 2026.